Article Text

Download PDFPDF

Short report
Th1 is the predominant helper T cell subset that produces GM-CSF in the joint of rheumatoid arthritis
  1. Hisakata Yamada1,2,3,
  2. Akihisa Haraguchi4,
  3. Koji Sakuraba2,
  4. Ken Okazaki4,
  5. Jun-Ichi Fukushi4,
  6. Hideki Mizu-Uchi4,
  7. Yukio Akasaki4,
  8. Yukio Esaki2,
  9. Satoshi Kamura2,
  10. Kenjiro Fujimura2,
  11. Masakazu Kondo3,
  12. Hisaaki Miyahara2,
  13. Yasuharu Nakashima4 and
  14. Yasunobu Yoshikai1
  1. 1 Divsion of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
  2. 2 Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
  3. 3 Kondo Clinic for Rheumatology and Orthopaedics, Fukuoka, Japan
  4. 4 Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan
  1. Correspondence to Dr Hisakata Yamada; hisaky{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Granulocyte macrophage colony-stimulating factor (GM-CSF), an immunomodulatory cytokine, is an emerging therapeutic target of rheumatoid arthritis (RA).1 Although GM-CSF is produced by various types of cells, including synovial fibroblasts, the importance of GM-CSF-producing CD4 T cells in the pathogenesis of RA was reported.2 Moreover, GM-CSF has been shown to be the critical effector cytokine produced by interleukin (IL)-23-stimulated Th17 cells in mice, leading to the prevailing notion that GM-CSF is a Th17-related cytokine.3 However, in humans, a distinct subset of CD4 T cells that produce only GM-CSF has recently been identified.4 The ‘GM-CSF-only’ T cells are characterised by the lack of lineage defining cytokines (interferon (IFN)-γ, IL-17 and IL-4) and are regulated independently of the master transcriptional regulators, T-bet, RORγt or GATA3. Furthermore, in contrast to mice, GM-CSF production by human CD4 T cells was promoted in Th1 conditions and was also detected in Th1 cells. At present, it is unclear which helper CD4 T cell subsets produce GM-CSF in human RA joints. Therefore, in this study, we performed multicolour flow cytometric analysis of cytokine production in CD4 T cells from patients with RA.

Lymphocytes in the peripheral blood (PB) and in joints from the same patients were analysed to compare the profiles of cytokine production. Synovial fluid (SF) samples were obtained from seven patients by arthrocentesis, while synovial membrane (SM) samples were obtained from seven other patients who underwent joint replacement surgery. The mean age and disease duration of the patients was 63.5±15.5 and 16.5±10.1 years, respectively. Twelve patients (86%) were positive for RF and/or anti-CCP2 antibody, and the mean C reactive protein level was 1.2±1.1 mg/dL. In total, 11 (79%), 10 (71%) and 4 (29%) patients received …

View Full Text